Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TELA Bio (TELA) Income from Continuing Operations (2018 - 2026)

TELA Bio has reported Income from Continuing Operations over the past 8 years, most recently at 30260000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 3.46% year-over-year to 30260000.0; the TTM value through Dec 2025 reached 470000.0, down 23.58%, while the annual FY2025 figure was 470000.0, 38.08% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 30260000.0 at TELA Bio, up from 8603000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 30260000.0 in Q4 2025 and troughed at 13623000.0 in Q4 2023.
  • A 5-year average of 6215950.0 and a median of 10445500.0 in 2022 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 314.7% in 2024 and later tumbled 98.98% in 2025.
  • Year by year, Income from Continuing Operations stood at 8576000.0 in 2021, then fell by 23.75% to 10613000.0 in 2022, then decreased by 28.36% to 13623000.0 in 2023, then soared by 314.7% to 29248000.0 in 2024, then increased by 3.46% to 30260000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for TELA at 30260000.0 in Q4 2025, 8603000.0 in Q3 2025, and 9923000.0 in Q2 2025.